Experimental and clinical studies demonstrated a clear association of sporadic CRC and inflammation-associated colorectal cancer with IL-6 signaling, although the specific mechanism through which IL-6 plays a role during CRC onset and progression has not been completely clarified. The gene discussed is IL6; the disease is colorectal cancer.